Mon, Dec 22, 2014, 1:57 PM EST - U.S. Markets close in 2 hrs 3 mins

Recent

% | $
Quotes you view appear here for quick access.

Novadel Pharma Inc. Message Board

  • leonia5pbb leonia5pbb Feb 21, 2013 10:46 PM Flag

    Read the good things about NVDL

    As of February 2013:

    1) 61 million shares held by insiders and 5% holders, 38% of all the shares, They sold NONE the past 2 years
    2) very low debt here, 6 million dollars is nothing compared with other companies
    3) partnership or a buyout is very possible, the company has stated that they are looking into a "strategic partnership"
    4) NVDL already has a revenue stream from 2 FDA approved drugs
    5) NVDL has valuable and special patents including international, 92 patents
    6) the float here is NOT high compared with many other stocks, 134 million shares minus the 61 million shares held by insiders and 5% holders
    7) very low market cap now, only 2 million dollar market cap means NVDL is undervalued
    8) insiders are NOT selling any shares and they were buying a lot more shares over the last 2 years at much higher prices
    9) Low share price now just means greater upside share price potential in the future
    10) 1 dollar price target for NVDL right now on Yahoo Finance. Yahoo Finance constantly updates this so paid basher dismisses price target, WHY?
    11) NVDL received 250,000 dollars in previous licensing deal
    12) two FDA approved drugs giving off a revenue stream right now
    13) mist technology is unique and valuable
    14) new partner: Rechon (distributor and manufacturer for EU and Asian markets) huge revenue stream potential in the future
    15) new drug candidates under development including duromist (EU and Asian markets first or global market with new partner deal). Duromist can generate many millions of dollars.
    16) very small quantity of shares available at the current share price on the "ask", price jumps on low volume means nobody wants to sell their shares
    17) NVDL is NOT pumped anywhere or talked about anywhere now, people just do NOT know about NVDL and what they have and its potential
    18) Paid bashers here bashing every day trying to create doubt, fear, turmoil and confusion just means something great here otherwise those people would not waste one minute of their time here with their agendas every single day
    19) Nobody is selling their NVDL shares now no matter what the paid bashers here claim
    20) Big pharma would benefit from buying NVDL right now
    21) their drug pipeline is great especially DUROMIST and Zensana and other drugs which are in development!!
    22) "Confidential Treatment SEC filing" applies through the year 2016
    23) Royalty and Licensing agreements already in place for future revenues
    24) Very recent expanded medical insurance coverage for the drug Zolpimist from many insurance companies proves that Zolpimist is a great drug, safe and effective
    25) NVDL received a special financial grant for a lot of money from the state of New Jersey for their drug "Duromist" which has so far been proven to be safe and effective in clinical trial but more testing is needed
    26) "bankruptcy" is a total myth and lie spread by desperate paid bashers who use many different aliases to bash this stock all day long every single day, 2 full years they have been posting that bankruptcy nonsense here so where is the bankruptcy?
    27) other 2 cent stocks have gone up to 50 cents and higher. The stock MJNA was 2 cents a few months ago and this month of February price hit 50 cents. There are many others that did the same thing. TTNP was 2 cents 4 years ago and now is above 2 dollars. SIRI was 5 cents 4 years ago and now is above 3 dollars, long list of others.
    28) NVDL is seeking a waiver now for any fees owed to the FDA
    .
    Let other people know to just check out what NVDL has and its great upside potential.
    No better time to be buying shares than right now.
    Maybe that is why insiders and 5% holders sold NONE of their NVDL shares for more than 2 years.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Paid basher tallijerk / toppedout can not dispute one thing.

      • 3 Replies to leonia5pbb
      • My response to your list...

        1) 61 million shares held by insiders and 5% holders, 38% of all the shares, They sold NONE the past 2 years - You can't sell your shares when you have material non-public information, such as trying to sell or partner your company. This is meaningless.
        2) very low debt here, 6 million dollars is nothing compared with other companies - $6million is huge when you have no cash and your cashflow doesn't pay your costs
        3) partnership or a buyout is very possible, the company has stated that they are looking into a "strategic partnership" - very true, if this is good or bad for us depends on what we get after the SUDA deal or some other deal. It is the only reason to hold these shares since their cashflow cannot sustain this business, let alone developing other products
        4) NVDL already has a revenue stream from 2 FDA approved drugs - the revenue stream does not cover costs. This is actually a negative.
        5) NVDL has valuable and special patents including international, 92 patents - how many are relevant vs. irrelevant we do not know. All we know is they have around 90 of them. The SUDA deal should tell us what they are worth since they are looking to sell them to SUDA.
        6) the float here is NOT high compared with many other stocks, 134 million shares minus the 61 million shares held by insiders and 5% holders - valid point if we ever get some positive news. However, there is no float because they are teatering on a bankruptcy and there is no point in selling shares when we MAY get soemthing out of a sale. I agree this is a positive for this stock.
        7) very low market cap now, only 2 million dollar market cap means NVDL is undervalued - hard to call a company undervalued when they can't cover their bills and their cashflow doesn't cover their costs. They can't afford to pay their $6 million bill so why do you think they should be valued higher than $2 million?
        8) insiders are NOT selling any shares and they were buying a lot more shares over the last 2 years at much higher prices - irrelevant, as stated above they can't sell their shares now
        9) Low share price now just means greater upside share price potential in the future - agree, if this company finds a way to exist in the future and if they can generate some meaningful cashflow. Their current 2 drugs don't generate enough cash and they cant afford to invest in new ones.
        10) 1 dollar price target for NVDL right now on Yahoo Finance. Yahoo Finance constantly updates this so paid basher dismisses price target, WHY? So who is giving it the $1 price target because I want to make sure I never invest in their recommendation. It is probably outdated or based on trading activity and the 1 day the stock had the spike because of the offshore company pump could have caused a technical model to spit that out. No fundamentals support a $1 number.
        11) NVDL received 250,000 dollars in previous licensing deal - money is long, long gone. This is irrelevant
        12) two FDA approved drugs giving off a revenue stream right now - as stated above the produce an immaterial cash flow that doesn't cover their costs
        13) mist technology is unique and valuable - it may be and we hope we find that in the SUDA deal, but we'll see
        14) new partner: Rechon (distributor and manufacturer for EU and Asian markets) huge revenue stream potential in the future - huge potential, depends on your definition of huge. So far its been lame.
        15) new drug candidates under development including duromist (EU and Asian markets first or global market with new partner deal). Duromist can generate many millions of dollars. - they don't have the cash to fund it. If they can't fix the currennt situation it won't matter, but it does provide nice upside if they can work their way out of this mess.
        16) very small quantity of shares available at the current share price on the "ask", price jumps on low volume means nobody wants to sell their shares - jumps is a very exaggerated word considering the price this has been at for the last 3 years. We have seen one jump because of the offshore company pumping and even that we a few pennies.
        17) NVDL is NOT pumped anywhere or talked about anywhere now, people just do NOT know about NVDL and what they have and its potential - company is teatering on bankruptcy. No one will invest until this gets worked out.
        18) Paid bashers here bashing every day trying to create doubt, fear, turmoil and confusion just means something great here otherwise those people would not waste one minute of their time here with their agendas every single day - do they bash the stock or you for your misleading posts
        19) Nobody is selling their NVDL shares now no matter what the paid bashers here claim - why would anyone sell now. I'll risk my 1.5cents per share against the possibility they work their way out of this. The difference between selling now and losing it all is not much, so you hold.
        20) Big pharma would benefit from buying NVDL right now - if so why are they not knocking down the door. Novadel is in deep trouble and they all now it and know they can get it cheap and yet they still have not been sold. What does that tell you.
        21) their drug pipeline is great especially DUROMIST and Zensana and other drugs which are in development!! - this is definitely upside as ocvered a few times above. However, they can't fund it so it is pie in the sky right now
        22) "Confidential Treatment SEC filing" applies through the year 2016 - where is the cash, thats all that matters and we are not seeing it?
        23) Royalty and Licensing agreements already in place for future revenues - most of the cash goes to someone else and sales have not been attractive so not sure how much this can generate
        24) Very recent expanded medical insurance coverage for the drug Zolpimist from many insurance companies proves that Zolpimist is a great drug, safe and effective - definitely a positive, but need to see a lot more cash quickly
        25) NVDL received a special financial grant for a lot of money from the state of New Jersey for their drug "Duromist" which has so far been proven to be safe and effective in clinical trial but more testing is needed - as already mentioned above the cash is long gone and irrelevant today
        26) "bankruptcy" is a total myth and lie spread by desperate paid bashers who use many different aliases to bash this stock all day long every single day, 2 full years they have been posting that bankruptcy nonsense here so where is the bankruptcy? the company themselves have stated this is a real possibility if they can't partner/sell the company. Are you bipolar?
        27) other 2 cent stocks have gone up to 50 cents and higher. The stock MJNA was 2 cents a few months ago and this month of February price hit 50 cents. There are many others that did the same thing. TTNP was 2 cents 4 years ago and now is above 2 dollars. SIRI was 5 cents 4 years ago and now is above 3 dollars, long list of others. - irrelevant and an example that can be used for any stock. all that is relevant are the facts and circumstances for Novadel which right now don't look very promising
        28) NVDL is seeking a waiver now for any fees owed to the FDA - lets hope they get it or it is game over

        Since you took the time to pull together this list I felt someone should respond to it with some detail. Unfortunately the vast majority of your positive stock points are wrong, misleading or hope-based. This stock is in deep trouble and they can't pay their bills. That is the reality on this stock.

      • Hahaha....You GD M0ron, there is nothing good about this POS

      • Too bad nobody knows about NVDL now, NOBODY.

 
NVDL
0.0061-0.0019(-23.75%)1:36 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.